Victoria A Johnson,Vincent Calvez,Huldrych F Günthard et al.
Victoria A Johnson et al.
This November 2011 edition of the IAS-USA drug resistance mutations list updates the figures last published in December 2010 (Johnson VA et al, Top HIV Med, 2010;18:156-163).
Safer conception interventions for HIV-affected couples: implications for resource-constrained settings [0.03%]
人类免疫缺陷病毒阳性夫妇安全受孕干预措施：资源匮乏地区的应用意义分析
Rachelle J Chadwick,Joanne E Mantell,Jennifer Moodley et al.
Rachelle J Chadwick et al.
Developing and testing safer conception methods that reduce HIV transmission to HIV-seronegative partners in serodiscordant couples and reduce superinfection in HIV-seroconcordant couples is a crucial but often unaddressed component of HIV ...
Geetanjali Chander
Geetanjali Chander
Alcohol use is common among persons with HIV infection and is associated with worse HIV treatment outcomes. Patients with hazardous levels of use are less likely to be receiving antiretroviral therapy, to be adherent to therapy, and to achi...
Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder [0.03%]
人类免疫缺陷病毒疾病的中枢神经系统并发症：与人类免疫缺陷病毒感染相关的神经认知障碍
Scott Letendre
Scott Letendre
HIV-associated neurocognitive disorder (HAND) is the result of neural damage caused by HIV replication and immune activation. Potent antiretroviral therapy has reduced the prevalence of severe HAND but not mild to moderate HAND. Brief sympt...
When patients cannot take pills: antiretroviral drug formulations for managing adult HIV infection [0.03%]
当患者不能服药时：用于治疗成人艾滋病病毒感染的抗逆转录病毒药物剂型
Chessa R Nyberg,Brooke Y Patterson,Meghan M Williams
Chessa R Nyberg
Providing antiretroviral therapy for the HIV-infected population is a complex and challenging task. Treatment is often complicated by the shifting demographic of HIV-infected patients that now includes a large aging population in which pati...
Advanced liver disease: what every hepatitis C virus treater should know [0.03%]
肝硬化并发症：每一个丙型肝炎治疗医生应该知道的事宜
Kenneth E Sherman
Kenneth E Sherman
Identification and treatment of advanced hepatitis C virus (HCV) infection is often challenging. Accurate fibrosis staging can be performed only by liver biopsy. For patients with advanced fibrosis (Metavir score, F3 or F4), progression to ...
Charles M Rice
Charles M Rice
The ultimate goal of hepatitis C virus (HCV) treatment is the eradication of the virus. Ongoing research continues to add to knowledge of the HCV life cycle, revealing new potential viral and host targets for the development of therapy. Und...
Barbara Taylor,Susan Olender,Timothy J Wilkin et al.
Barbara Taylor et al.
The 18th Conference on Retroviruses and Opportunistic Infections maintained its tradition of being the preeminent forum for detailing the state-of the-art in antiretroviral therapy. There were important presentations on investigational anti...
Anne F Luetkemeyer,Diane V Havlir,Judith S Currier
Anne F Luetkemeyer
Studies on new direct-acting antivirals (DAAs) for hepatitis C virus infection were a focus of the 2011 Conference on Retroviruses and Opportunistic Infections. Although the majority of the data were from HIV-uninfected patients, much-neede...
Serena S Spudich,Beau M Ances
Serena S Spudich
Issues relevant to the nervous system garnered substantial attention at the 18th Conference on Retroviruses and Opportunistic Infections. Several topics emerged as areas of importance both for informing current understanding of HIV-related ...